Physician's Weekly
JUNE 18, 2025
Healthcare Professionals Among healthcare professionals, potential barriers include lack of education, safety concerns, and obesity stigma/weight bias. Waldrop, MD , and colleagues identified barriers to obesity medications more broadly—and potential solutions. They published their insights in Nature Medicine.
The Medical Futurist
JUNE 21, 2025
To diagnose and treat a patient, a healthcare professional listens to the patient, reads their health files, looks at medical images and interprets laboratory results. These systems will considerably reduce the workload of – but not replace- human healthcare professionals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
My Green Doctor
MAY 3, 2025
Powering Health, Protecting the Planet – Why Renewable Energy Belongs in Every Clinic Healthcare professionals have always been trusted voices on public health. Once you have begun adopting worked sustainable practices into your own clinic, consider working within your professional societies to work for change.
GeriPal
JUNE 20, 2024
Incontinence and avoiding issues can present in an older individual, in some cases, just like they do a younger person. Biological aging or physiological aging varies from individual to individual. How do you think about this from a clinical perspective when you’re seeing individuals in your office? Everybody ages.
GeriPal
MAY 5, 2022
We talk with Nick and Meg about: Why hearing loss is important not just in geriatrics but also for those caring for seriously ill individuals. Communication techniques we can use when talking to individuals with hearing loss. But individuals who have hearing loss, there’s several problems. Five big manufacturers.
FDA Law
MAY 5, 2024
Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. Schedule III substances do not require manufacturing quotas.
GeriPal
MARCH 2, 2023
I also heard that if you look at all individuals in the US, about 4% of individuals are taking one of the gabapentinoids, 10% over 65. And for that reason, there was actually an enormous lawsuit, and the manufacturer was fined, now I think 20 years ago, in the millions and millions of dollars for off-label prescribing.
Expert insights. Personalized for you.
52 
Let's personalize your content